22，Batsakis JG,EI-Naggar AK.p53:Fifteen years after discovery Advanin AnatoPathol,1995,2:71～88
33，Govender D,Harilal P,Hadley GP,et al.p53 protein expression in nephroblastomas:apredictor of poor prognosis.Br J Cancer,1998,77(2):314～318
44，EL-Bahtimi R,Hazen Martin DJ,Re GG,et al.Immunophenotype,mRNA expression,and genestructure of p53 in Wilms tumors.Mod Pathol,1996,9(3):238～244
55，Karamitopoulou E,Perentes E,Diamantis I.p53 protein expression in central nervoussystem tumors:an immunohistochemical study with CMI polyvalent and DO-7 monoclonalantibodies.Acta Neuropathol Berl,1993,85(6):611～616
66，Eah PL,Looi LM,Chan LL.Immumohistochemical expression of p53 proteies in Wilmstumour:a possible association with the histological prognostic parameter ofanaplasia.Hitopathology,1996,28:49～54
77，Cahoti C,Thorner P,Malkin D,et al.Immunohistochemical detection of p53 in Wilms tumorscorrelates with unfavorable outcome.Am J Pathol,1996,148:1577～1589
2Sredni ST,de Camargo B, Lopes LF,et al.Immunohistochemical detection of p53 pro-tein expression as a prognostic indicator inWilms tumor. Med Pediatr Oncol, 2001 ,37.455-458.
3Farzaneh J, Delaram S, Mohammad R, etal. Immunohistochemical detection of p53protein expression as a prognostic factor inWilms tumor. Iran J Kidney Dis,2011,5 :149-153.
4Grundy PE,Breslow NE,Li S,et al. Loss ofheterozygosity for chromosomes lp and 16q isan adverse prognostic factor in favorable-his-tology Wilms tumor: a report from the Na-tional Wilms Tumor Study Group. J Clin On-col ,2005 ,23 ;7312-7321.
5Grundy PE, Telzerow PE, Breslow N,et al.Loss of heterozygosity for chromosomes 16qand Ip in Wilms tumors predicts an adverseoutcome. Cancer Res, 1994,54:2331 -2333.
